CURE vs. UCC
CURE (Direxion Daily Healthcare Bull 3x Shares) and UCC (ProShares Ultra Consumer Services) are both Leveraged Equities funds - CURE tracks the Health Care Select Sector Index (300%) while UCC tracks the Dow Jones U.S. Consumer Services Index (200%). Both are passively managed. Over the past 10 years, CURE returned 13.49%/yr vs 13.99%/yr for UCC. A 0.52 correlation means they provide meaningful diversification when combined. CURE charges 1.08%/yr vs 0.95%/yr for UCC.
Performance
CURE vs. UCC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CURE achieves a -7.96% return, which is significantly higher than UCC's -8.62% return. Both investments have delivered pretty close results over the past 10 years, with CURE having a 13.49% annualized return and UCC not far ahead at 13.99%.
CURE
- 1D
- -0.55%
- 1M
- 13.71%
- YTD
- -7.96%
- 6M
- -6.00%
- 1Y
- 28.51%
- 3Y*
- 3.05%
- 5Y*
- 1.51%
- 10Y*
- 13.49%
UCC
- 1D
- 0.57%
- 1M
- -4.37%
- YTD
- -8.62%
- 6M
- -10.29%
- 1Y
- 12.48%
- 3Y*
- 14.37%
- 5Y*
- -0.24%
- 10Y*
- 13.99%
CURE vs. UCC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | -7.96% | 22.55% | -8.47% | -9.40% | -20.51% | 88.30% | 5.02% | 55.66% | 2.82% | 69.32% |
UCC ProShares Ultra Consumer Services | -8.62% | 2.21% | 44.24% | 61.67% | -57.59% | 20.92% | 46.55% | 53.76% | -4.94% | 42.05% |
Correlation
The correlation between CURE and UCC is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.31 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.37 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.45 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.47 |
Correlation (All Time) Calculated using the full available price history since Jun 15, 2011 | 0.52 |
Over the past year, the correlation between CURE and UCC has dropped to 0.31 - well below their long-term average of 0.52, suggesting their price drivers have been diverging.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CURE vs. UCC — Risk / Return Rank
CURE
UCC
CURE vs. UCC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and ProShares Ultra Consumer Services (UCC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CURE | UCC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.32 | ||
| Sortino ratioReturn per unit of downside risk | +0.54 | ||
| Omega ratioGain probability vs. loss probability | 1.13 | 1.08 | +0.06 |
| Calmar ratioReturn relative to maximum drawdown | 0.85 | 0.35 | +0.51 |
| Martin ratioReturn relative to average drawdown | 1.94 | 0.97 | +0.97 |
Loading charts...
Drawdowns
CURE vs. UCC - Drawdown Comparison
The maximum CURE drawdown since its inception was -69.19%, smaller than the maximum UCC drawdown of -83.05%. Use the drawdown chart below to compare losses from any high point for CURE and UCC.
Loading charts...
Drawdown Indicators
| CURE | UCC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.19% | -83.05% | +13.86% |
Max Drawdown (1Y)Largest decline over 1 year | -31.10% | -29.14% | -1.96% |
Max Drawdown (3Y)Largest decline over 3 years | -51.93% | -48.01% | -3.92% |
Max Drawdown (5Y)Largest decline over 5 years | -52.23% | -61.77% | +9.54% |
Max Drawdown (10Y)Largest decline over 10 years | -69.19% | -61.77% | -7.42% |
Current DrawdownCurrent decline from peak | -26.94% | -18.41% | -8.53% |
Average DrawdownAverage peak-to-trough decline | -18.16% | -21.80% | +3.64% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.71% | 10.45% | +3.26% |
Volatility
CURE vs. UCC - Volatility Comparison
Direxion Daily Healthcare Bull 3x Shares (CURE) has a higher volatility of 14.30% compared to ProShares Ultra Consumer Services (UCC) at 12.41%. This indicates that CURE's price experiences larger fluctuations and is considered to be riskier than UCC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CURE | UCC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.30% | 12.41% | +1.89% |
Volatility (6M)Calculated over the trailing 6-month period | 30.87% | 27.05% | +3.82% |
Volatility (1Y)Calculated over the trailing 1-year period | 44.32% | 36.41% | +7.91% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.84% | 43.70% | +0.14% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.59% | 40.68% | +8.91% |
CURE vs. UCC - Expense Ratio Comparison
CURE has a 1.08% expense ratio, which is higher than UCC's 0.95% expense ratio.
Dividends
CURE vs. UCC - Dividend Comparison
CURE's dividend yield for the trailing twelve months is around 1.16%, less than UCC's 1.18% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 1.16% | 1.12% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% | 0.00% | 0.00% |
UCC ProShares Ultra Consumer Services | 1.18% | 1.10% | 0.17% | 0.04% | 0.25% | 0.00% | 0.02% | 0.17% | 0.18% | 0.14% | 0.21% | 0.14% |
Frequently Asked Questions
CURE and UCC have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CURE has higher volatility (14.30%) compared to UCC (12.41%). In terms of maximum drawdown, CURE dropped -69.19% vs UCC's -83.05%.
On 10-year performance, UCC leads with 13.99% vs 13.49% for CURE. On fees, UCC is cheaper at 0.95% per year. On volatility, UCC has been the lower-risk option at 12.41%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, UCC has performed better with a 13.99% return vs 13.49%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
UCC is cheaper with a 0.95% expense ratio, compared with 1.08% for CURE.
UCC has the higher dividend yield at 1.18%, compared with 1.16% for CURE.
CURE tracks Health Care Select Sector Index (300%), while UCC tracks Dow Jones U.S. Consumer Services Index (200%). They also come from different issuers: Direxion and ProShares. Their fees differ too: 1.08% for CURE and 0.95% for UCC.
CURE currently has the higher Sharpe Ratio (0.60 vs 0.28), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CURE and UCC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer